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The potential eﬀects of horizontal gene transfer on human health are an important item in the safety assessment of genetically mod-
ified organisms. Horizontal gene transfer from genetically modified crops to gut microflora most likely occurs with transgenes of
microbial origin. The characteristics of microbial transgenes other than antibiotic-resistance genes in market-approved genetically
modified crops are reviewed. These characteristics include the microbial source, natural function, function in genetically modified
crops, natural prevalence, geographical distribution, similarity to other microbial genes, known horizontal transfer activity, selective
conditions and environments for horizontally transferred genes, and potential contribution to pathogenicity and virulence in hu-
mans and animals. The assessment of this set of data for each of the microbial genes reviewed does not give rise to health concerns.
We recommend including the above-mentioned items into the premarket safety assessment of genetically modified crops carrying
transgenes other than those reviewed in the present study.
INTRODUCTION
The cultivation of genetically modified (GM) crops
has rapidly increased since their large-scale commercial
introduction in 1996. The acreage of GM crops in 2004
amounted to 81 millions of hectares worldwide, while the
number of nations that adopt GM crop cultivation was
also increasing [1]. Before GM crops and other geneti-
cally modified organisms (GMOs) are allowed to enter the
market, the law inmany nations requires that these organ-
isms and/or derived products be assessed for their safety.
To this end, the applicant, which is in most cases a com-
pany that has developed and produced a GMO, provides
a dossier to the national authorities, which, among oth-
ers, contains safety data. Whereas national laws and reg-
ulatory procedures may diﬀer among each other, the reg-
ulatory safety assessment itself follows an internationally
harmonised approach. International organisations like
the United Nations’ Food and Agriculture Organisation
(FAO) and World Health Organisation (WHO) as well as
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the Organisation for Economic Cooperation and Devel-
opment (OECD) and International Life Sciences Institute
(ILSI) have initiated this harmonisation. It has recently
culminated into the issuance of FAO/WHO Codex Ali-
mentarius guidelines for the safety assessment of foods
derived from GM plants and microorganisms [2]. Cen-
tral in the harmonised approach is the comparative safety
assessment, which entails the comparison of a GMO with
a conventional counterpart that has a history of safe use
[3]. This comparison may include, for example, pheno-
typic characteristics (eg, field behaviour) and composi-
tion (eg, macronutrients, micronutrients, antinutrients)
of a GMO and its comparator. Based upon the diﬀerences
found during the comparison between the GMO and its
comparator, it can be decided which further safety tests
are needed. Issues that are commonly addressed during
the safety assessment include the molecular characteri-
sation (eg, introduced genes), the potential for horizon-
tal gene transfer, potential allergenicity, potential toxicity,
nutritional characteristics, environmental eﬀects, and un-
intended eﬀects of the genetic modification (reviewed in
[4]).
Horizontal gene transfer
Various mechanisms exist for horizontal gene trans-
fer between microorganisms, such as phage transduction,
conjugation, and transformation by free DNA (eg, [5]).
The possible scenario for gene transfer between GM crops
and microorganisms is, however, limited to transforma-
tion with free DNA.
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A number of studies and reviews have focused on
the transfer of genes from GM plants to soil- and plant-
related microorganisms (eg, [6, 7, 8, 9, 10]). The results of
some of these studies indicated that transgenes from GM
crops are most likely transferred if they contain suﬃcient
similarity with the corresponding genes in the recipient
because homologous recombination is the most probable
mechanism of transfer (eg, [11]). It has, however, recently
been observed that under conditions of simulated light-
ning, which might cause electroporation of recipient cells,
DNA could be transferred to isolated soil microbes [12].
Other factors that are important for transformation
with DNA are the natural or induced competence of the
recipientmicroorganisms, such as the natural competence
of Campylobacter species. Some microorganisms, such
as Salmonella typhimurium, have mismatch repair sys-
tems that form a barrier for recombination between even
highly similar sequences (eg, reviewed for Salmonella by
[13]). Some bacteria can develop natural/chemical com-
petence under certain environmental conditions [6].
In addition, the transgenes in plants may have been
linked to promoters with optimal activity in the cells
of plants. Sequences promoting expression in eukaryotes
and prokaryotes are generally known to be diﬀerent. Nev-
ertheless, Jacob et al [14] observed that eukaryotic pro-
moters from, for example, the cauliflower mosaic virus,
potato, and tobacco, triggered expression of inserted re-
porter genes in five eubacterial species. In addition, Lewin
et al [15] observed that random sequences from yeast may
exhibit promoter activity in bacteria.
Jonas et al [16] estimated the potential dietary in-
take of transgenic DNA present in food. The estimated
intake of transgenic DNA from maize, soya, and pota-
toes amounted to approximately 0.38 µg per day, assum-
ing that only GM crops are consumed. This is about
0.00006% of the total DNA intake of 0.6 g per day.
Still this is a “worst-case” scenario as DNA is prone to
degradation in food matrices or during food processing
(reviewed in [16]). On the other hand, also the protection
of DNA against the activity of DNase I in, for instance,
fermented sausages has been described [17].
In addition, the integrity of the DNA is countered
by the activity of DNA degrading enzymes released by
the pancreas and intestinal epithelial cells during its pas-
sage through the gastrointestinal tract. Nevertheless, it has
been shown that DNA can persist in the gastrointestinal
tract [16, 18, 19] and consequently be available for up-
take by intestinal competent bacteria. For example, the
survival of cp4 epsps transgenes in the small intestines of
human volunteers who consumed a GM soy product has
recently been demonstrated in a study by Netherwood et
al [20], so there is a chance for exposure of intestinal mi-
croorganisms to free transgenic DNA. However, the pref-
erential site for transformation of competent bacteria is
probably in the colon. This is because the colon contains
the largest population of bacteria within the gastrointesti-
nal tract. Whilst the amount of DNA reaching the colon
may only be a fraction of what is consumed, DNA is less
rapidly degraded there. For example, ex vivo and in vivo
rat models simulating human gut conditions showed that
DNA is rapidly degraded in the upper part of the gastroin-
testinal tract, but to a lesser degree in the lower part [19].
Besides the integrity of DNA, the transformability,
that is, the likelihood that this DNA will transform bac-
teria in food or in the gut, should be taken into account.
In foods, transformation of Escherichia coli by plasmid
transfer was proven to occur in all 12 food products in-
vestigated [21]. In addition, transfer of DNA to Strepto-
coccus gordonii was also proven in homogenates of blood
sausages by marker rescue experiments [22]. Kharazmi et
al [23] observed the transfer of nptII kanamycin resis-
tance marker gene from transgenic potatoes to Bacillus
subtilis with defective nptII by homologous recombina-
tion under in vitro conditions. Based upon the observed
frequencies of transfer, these authors calculated the prob-
ability of the transfer of the intact nptII gene from con-
sumed transgenic potatoes to microbes. Because marker
rescue by homologous recombination is the most proba-
ble mechanism for gene transfer, these calculations can be
considered a “worst-case” scenario in view of other possi-
ble mechanisms of horizontal transfer of transgenes from
GM crops.
Potential health effects
Currently, the focus of the assessment of potential
transfer from GMOs is on antibiotic-resistance marker
genes, as, for example, in the previously mentioned FAO/
WHO Codex Alimentarius guidelines. In a more gen-
eral sense, antibiotic resistance among microbial hu-
man pathogens is currently a top priority issue in
health care and research. The horizontal gene transfer
of antibiotic-resistance genes between microorganisms
has been important for the development of antibiotic-
resistant pathogens.
In modern biotechnology, some antibiotic-resistance
marker genes are used for the successful molecular
cloning in bacteria and plants because they enable growth
on antibiotic-containing media after the genetic modi-
fication process. These marker genes are therefore use-
ful in the development phase, but have no function in
the final product. An example of an antibiotic-resistance
gene that is present in many commercial GM crops is the
kanamycin-resistance gene nptII encoding the neomycin
phosphotransferase II enzyme. The use of this gene has
been considered to be safe based upon the widespread oc-
currence of kanamycin resistance in microorganisms in
the environment, the low clinical relevance of kanamycin,
and the low likelihood of transfer to microorganisms af-
ter consumption of GM products containing nptII (eg, re-
viewed by [5]).
For a more elaborate discussion on mechanisms of
gene transfer, antibiotic-resistance genes, and horizontal
gene transfer from GM crops, as well as a classification of
antibiotic-resistance markers based upon their risk char-
acteristics, we refer to a recent review by the working
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group on horizontal gene transfer of the EU-sponsored
thematic network ENTRANSFOOD [5].
Besides the horizontal transfer of antibiotic-resistance
genes, the transfer of “pathogenicity islands” has played
an important role in the evolution of pathogenic strains
of microorganisms, such as pathogenic strains of E coli
and Salmonella enterica [24, 25]. There are many factors
that can influence the virulence and human pathogenicity
of microorganisms. These include, for example, the for-
mation of certain adhesion molecules that bind to host
cells, such as adhesins of bacterial pili. In addition, secre-
tion systems containing multiple proteins that are trans-
ferred from pathogens to the host cells help pathogens
invade these cells. Pathogens may also produce enzymes
and toxins that cause damage in host cells, which may
facilitate entry into tissues (eg, proteinases of fungi in-
fecting lungs) or suppress immune response (eg, dam-
age to blood cells). In addition, pathogens may be self-
suﬃcient for certain nutritional compounds or be able
to sequester them, such as by producing siderophores
that complex with iron. Other common characteristics are
quorum sensing by “autoinducing” substances, the regu-
lation of expression of pathogenicity-associated genes at
the appropriate stage of infection, formation of capsules,
and the ability of fungi to change their morphology. These
and other aspects that influence the pathogenicity of mi-
croorganisms are reviewed elsewhere in more detail (eg,
[26, 27]).
The source, function, and characteristics of transgenes
and derived products, which may or may not be associ-
ated with pathogenicity, are commonly considered dur-
ing the safety assessment of GM crops. While the assess-
ment in practice may also include the potential horizon-
tal transfer of pathogenicity-associated transgenes, such
as required by the EU [28], this issue is not explicitly men-
tioned in the previouslymentioned FAO/WHOCodex Al-
imentarius guidelines, which focus solely on the transfer
of antibiotic-resistance genes.
Scope of this study
In this article, we discuss the characteristics of trans-
genes of microbial origin that have been introduced into
GM crops that have received regulatory approvals for food
use. The reason for limiting the survey to transgenes of
microbial origin is because they are the most likely to
be transferred to microorganisms based on the follow-
ing considerations. As stated above, homologous recom-
bination between transgenes from GM crops and genes
present in microbes is the most probable mechanism
for horizontal gene transfer. This implies that similar se-
quences should already be present in the microorganisms
before transfer can occur. Genetic modification allows for
the introduction of DNA from unrelated species, includ-
ing microbes, into crops. Indeed, a number of coding se-
quences of microbial origin have been introduced into
various commercially approved GM crops (Table 1). The
original nucleotide composition of these genes may have
been optimised in some cases for expression in plants, due
to diﬀerences, for example, in codon preference between
bacteria and plants. In addition, plant-specific promoter
and terminator sequences, as well as other sequences (in-
trons, transition peptides) may have been introduced with
the transgene to facilitate gene expression in plants.
The following issues are addressed for each transgene:
(i) microbial source of the gene, including occur-
rence and pathogenicity of themicroorganism from
which the gene originates;
(ii) natural function, such as the role that the gene
product has in its native host;
(iii) natural prevalence of the gene in microorganisms
other than the gene source;
(iv) geographical distribution, that is, the geographical
locations where the gene and the microbial species
that harbor it occur;
(v) similarity of the DNA of the transgene construct to
other naturally occurring microbial genes, that is,
a FASTA analysis has been performed to search for
microbial analogues of
(1) the gene from its microbial source,
(2) the codon-modified transgene version intro-
duced into GM crops;
(vi) known horizontal gene transfer activity of the gene;
among others, the location of the native micro-
bial transgene on chromosome, plasmid, or phage
is considered, since this might predispose the gene
to transfer, for example, through conjugation (plas-
mid) or transduction (phage); in addition, data that
indicate that transfer might have occurred are also
considered;
(vii) selective conditions and environments for bacteria
carrying horizontally acquired genes;
(viii) potential of the transgene to cause microbial
pathogenicity or to increase virulence;
(ix) conclusion: based on the data considered for each
gene, we conclude on whether horizontal gene
transfer of the transgene in GM crops to microor-
ganisms would be likely to cause or aggrevate any
adverse health eﬀects in consumers.
The FASTA analysis in search for microbial genes that
are similar to the transgenes served two purposes. First,
the occurrence of analogues in other microbes might in-
dicate the extent of the dispersal of the native transgene in
species. Second, the results help to identify which of these
analogues are amenable to homologous recombination.
For homologous recombination to occur, matching seg-
ments should have a minimal length. For example, iden-
tical flanking segments of at least 20 bp are required to
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Table 1. Microbial transgenes in GM crops that have been approved for human food usea,b,c.
Transgene product Origin Trait Nationd
Herbicide resistance
Bromoxynil nitrilase Klebsiella pneumonia ozaenae Bromoxynil resistance AUS-NZ, CAN, USA
Enolpyruvylshikimate phosphate Agrobacterium CP4 Glyphosate resistance AUS-NZ, CAN, EU, USA
synthase
Glyphosate oxidoreductase Achromobacter LBAA Glyphosate resistance AUS-NZ, CAN, EU, USA
Phosphinothricin acetyltransferase Streptomyces hygroscopicus Glufosinate resistance AUS-NZ, CAN, EU, USA
(bar)
Phosphinothricin acetyltransferase Streptomyces viridochromogenes Glufosinate resistance AUS-NZ, CAN, EU, USA
(pat)
Male sterility and fertility restoration
Barnase Bacillus amyloliquefaciens Male sterility AUS-NZ, CAN, EU, USA
Barstar Bacillus amyloliquefaciens Fertility restorer AUS-NZ, CAN, EU, USA
DNA adenine methylase Escherichia coli Male sterility USA
Plant hormone metabolism
Aminocyclopropane-carboxylate Pseudomonas 6G5 Prolonged ripening USA
deaminase
S-adenosylmethionine hydrolase Escherichia coli bacteriophage Prolonged ripening USA
T3
Transformation marker
Beta glucuronidase (uidA) Escherichia coli Colour reaction AUS-NZ, CAN, USA
Nopaline synthase Agrobacterium tumefaciens Nopaline synthesis CAN, USA
pTiC58
Insecticidal proteins
Crystal protein Cry1Ab Bacillus thuringiensis kurstaki Insect resistance AUS-NZ, CAN, EU, USA
Crystal protein Cry1Ac Bacillus thuringiensis kurstaki Insect resistance AUS-NZ, CAN, EU, USA
Crystal protein Cry1Fa Bacillus thuringiensis aizawai Insect resistance AUS-NZ, CAN, USA
Crystal protein Cry2Aa Bacillus thuringiensis kurstaki Insect resistance AUS-NZ
Crystal protein Cry2Ab Bacillus thuringiensis kurstaki Insect resistance AUS-NZ, CAN, USA
Crystal protein Cry3Aa Bacillus thuringiensis tenebrionis Insect resistance AUS-NZ, CAN, USA
Crystal protein Cry3Bb Bacillus thuringiensis EG4961 Insect resistance AUS-NZ, CAN, USA
Crystal proteins Cry34Ab, Cry35Ab Bacillus thuringiensis PS149B1 Insect resistance USA
aAntibiotic-resistance marker genes are not included.
bSources of information: [29, 30, 31, 32].
cThe American Food and Drug Administration (FDA) does not formally approve GM foods; “USA” in the fourth column indicates that the particular
transgene is present in GM crops for which a consultation with the FDA has been completed.
dAUS-NZ, Australia-New Zealand; CAN, Canada; EU, European Union; USA, United States of America.
insert DNA by homologous recombination in Escherichia
coli [33, 34], such that the minimal length would corre-
spond to 2 × 20 bp. It should be noted that this repre-
sents a minimum requirement and that longer segments
of identical nucleotides will have an increased likelihood
of recombining. In addition, the presence of shorter iden-
tical segments (< 20 bp) in the DNA surrounding the re-
combination site facilitates complex formation with the
incoming DNA, thereby increasing the eﬃciency of the
subsequent recombination (eg, [35]). Therefore, the oc-
currence of both a high overall similarity and identical
stretches above a particular length indicates an increased
probability of homologous recombination with the trans-
gene. Given that in many cases the native sequences and
not the plant-optimised transgenic sequences have been
used for the FASTA analysis, the outcomes may represent
a “worst-case” scenario.
The FASTA analysis, which compared the transgene
with microbial genes, was carried out using the EBI web-
site’s FASTA facility with default settings being used. More
specifically, the sequences of interest were compared with
the EBI’s sub-databases with nucleotide sequences de-
rived from prokaryotes, bacteriophages, and fungi (Eu-
ropean Bioinformatics Institute’s nucleic acid database,
http://www.ebi.ac.uk/fasta 33/nucleotide.html). From the
results, sequences frommicroorganisms that showed sim-
ilarity with the sequence of interest and that did not be-
long to the same species as the gene source were consid-
ered. Of these sequences, those were identified that com-
plied with one or both of two criteria. The first crite-
rion is an expectation (E) value of 1∗10−30 at maximum,
which is a statistical term indicating the likelihood that an
alignment with the same similarity score would occur by
chance within the chosen database [36]. This arbitrarily
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chosen E value is stringent and therefore corresponds to a
high degree of similarity between aligned sequences. The
other criterion is identical nucleotide stretches of mini-
mally twice 20 nucleotides (2 × 20 bp) required for ho-
mologous recombination, as explained above.
In a similar fashion, another review that has recently
been published dealt with the microbial transgenes and
sequences present in GM crops and the significance of
their transfer to soil bacteria [37].
OVERVIEWOF TRANSGENES AND THEIR
CHARACTERISTICS
Bromoxynil nitrilase (BXN)
Microbial source
The bxn gene used for genetic modification of crops
has been cloned from an isolate of the bacterium Kleb-
siella pneumonia var ozaenae found in bromoxynil-
contaminated soil. This isolate was capable of growing on
bromoxynil-containing media and utilising the ammonia
released from converted bromoxynil as its sole source of
nitrogen [38, 39].
Natural function
Bromoxynil nitrilase (BXN) converts the cyano (ni-
trile, CN)-moiety of the bromoxynil molecule to a car-
boxyl (COOH)-moiety. Conversion of bromoxynil by ni-
trilase enzymes from other microorganisms is much less
eﬃcient. The Klebsiella BXN displays substrate speci-
ficity towards aromatic molecules that have halogen sub-
stituents in the meta positions with respect to the cyano
moiety [40].
A putative function of these nitrile-degrading en-
zymes in conjunction with aldoxime dehydratase en-
zymes is the degradation of plant-produced aldoxime
compounds by soil microorganisms [41].
Function in GM crops
Genetic engineering of BXN into crop plants renders
them resistant to application of the herbicide bromoxynil
[39].
Natural prevalence
In a broader perspective, nitrilases occur in a range of
microorganisms and plants. Also other related enzymes
convert nitriles, such as NHases and amidases [42, 43].
Phylogenetic analysis revealed that BXN is closely related
to fungal cyanide hydratase enzymes, which convert ni-
triles to amides [43]. The nitrile-metabolising capacity of
some microorganisms is currently exploited in industrial
processes, like the production of acrylamide from acry-
lonitrile [42, 43].
Geographical distribution
A recent study reports the presence of nitrile-
degrading activity in bacteria and actinomycetes from
soil and deep-sea samples of wide-ranging geographi-
cal origins. For example, bromoxynil-metabolising, gram-
negative bacteria were detected in soil samples from Ar-
gentina and Namibia [44].
Similarity to othermicrobial genes
The native gene sequence used for FASTA analysis was
derived from K pneumoniae var ozaenae, accession J03196
[45], with a coding sequence size of 1050 bp. No similari-
ties corresponding to the threshold criteria were observed
(Table 2). The codon-modified transgene sequence of bxn,
as has been introduced into GM crops, was not available
for FASTA analysis.
Known horizontal gene transfer activity
The bxn gene is located on an 82-kDa plasmid in K
pneumoniae var ozaenae [46]. After artificial transfer to
E coli, this plasmid was found to be stably maintained in
cells grown in the presence of bromoxynil. However, in the
absence of bromoxynil, a 14-kDa deletion of the plasmid
with concurrent loss of bxn was observed. This deletion
was probably recA-dependent [46]. There was no infor-
mation available regarding the horizontal transfer of the
bxn gene.
Selective conditions and environments
As stated above, soil bacteria harbouring the bxn gene
were able to utilize bromoxynil as the sole nitrogen source.
Furthermore, after artificial transfer to E coli, the native
plasmid harbouring the bxn gene was stably maintained
in the presence of bromoxynil, whereas a fragment con-
taining the bxn gene was deleted in the absence of bro-
moxynil. In addition, its putative natural function is the
metabolism of plant-secreted aldoxime compounds. We
therefore conclude that, in theory, bacteria carrying an ac-
tive bxn gene would have a selective advantage in soils,
such as crop land, to which the herbicide bromoxynil is
applied, or in the vicinity of plants secreting aldoxime
compounds.
Potential for pathogenicity or virulence
K pneumonia var ozaenae, the source of the bxn gene,
is synonymous to Klebsiella ozaenae. This bacterium is
also known as a human pathogen associated with “ozena”
(atrophic rhinitis, an aﬀection of the upper respiratory
tract), as well as with other aﬀections, such as bac-
teremia and urinary tract infection [47]. No information
was available on the role that BXN might have in the
pathogenicity of its gene source, K pneumonia var ozae-
nae.
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Table 2. Similarity of native microbial transgenes to other microbial sequences.
Native genea Similarity Microorganism Gene accessionb
bxn No
cp4 epsps E < 1∗10−30 and 2× 20 bp Brucella melitensis AE009625; AF326475
Brucella suis AE014291c
Mesorhizobium loti BA000012
Sinorhizobium meliloti AL591783c
E < 1∗10−30 Bartonella henselae BX897699c
Bartonella quintana BX897700c
Bradyrhizobium japonicum BA000040c
Caulobacter crescentus AE006017c
Gluconobacter oxydans, CP000009
Rhodopseudomonas palustris BX572593c
Silicibacter pomeroyi CP000032c
Zymomonas mobilis AE008692
gox No
bar E < 1∗10−30 and 2× 20 bp Streptomyces X65195; M22827
viridochromogenes
pat E < 1∗10−30 and 2× 20 bp Streptomyces hygroscopicus X05822; X17220
barnase E < 1∗10−30 and 2× 20 bp Bacillus circulans Z29626
E < 1∗10−30 Bacillus intermedius X53697
Bacillus licheniformis AE017333c; CP000002c
Bacillus pumilus U06867
2× 20 bp B intermedius AJ006407
barstar No
dam E < 1∗10−30 and 2× 20 bp Salmonella enterica AL627281; AE016847
Salmonella typhimurium AE008860; U76993
Shigella flexneri AE016992
E < 1∗10−30 Actinobacillus actinomycetemcomitans AF263926
Erwinia carotovora BX950851
Haemophilus influenzae U32705c
Legionella pneumophila AE017354
Mannheimia succiniciproducens AE016827
Neisseria meningitidis AF091142c
Pasteurella multocida AE006162; AF411317
Photobacterium profundum CR378663c
Photorhabdus luminescens BX571859
Serratia marcescens X78412
Shewanella oneidensis AE015477c
Vibrio cholerae AE004329c; AF274317; AY341955
Vibrio parahaemolyticus BA000031c
Vibrio vulnificus BA000037; AE016801
Yersinia pestis AJ414141; AE017127; AE013998
Yersinia pseudotuberculosis BX936398c; AF274318
ACC deaminase E < 1∗10−30 and 2× 20 bp Achromobacter xylosoxidans AY604539d
Burkholderia mallei CP000011c
Burkholderia pseudomallei BX571966c
Enterobacter cloacae AF047840; AF047710
Pseudomonas fluorescens U37103
Pseudomonas brassicacearum AY604528d
Ralstonia solanacearum AL646080c
Variovorax paradoxus AY604531
E < 1∗10−30 Acidovorax facilis AY604529d
Agrobacterium tumefaciens AF315580c
Bradyrhizobium japonicum BA000040
Mesorhizobium loti AL672114c; BA000012
Penicillium citrinum AB038511
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Table 2. Continued.
Native genea Similarity Microorganism Gene accessionb
Pseudomonas sp M73488
Pseudomonas putida AY604533d
Pseudomonas syringae AE016869c
Rhizobium leguminosarum AF421376; AY604535d
Rhizobium sullae AY604534d
Rhodococcus sp AY604538d; AY604537d
Schizosaccharomyces pombe AL133522c
Variovorax paradoxus AY604530d; AY604532d
SAMase E < 1∗10−30 and 2× 20 bp Bacteriophage phiYeO3-12 AJ251805
uidA E < 1∗10−30 and 2× 20 bp Shigella sp AY698518d; AY698517d
Shigella boydii AY698415d; AY698417d;
AY698420d; AY698422d;
AY698424d; AY698425d;
AY698502d; AY698504d;
AY698506d; AY698509d;
AY698510d; AY698511d
Shigella dysenteriae AY698426d; AY698427d;
AY698428d; AY698430d;
AY698431d; AY698434d;
AY698435d; AY698473d;
AY698480d
Shigella flexneri AE005674; AE016983;
AY698414d; AY698416d;
AY698432d; AY698433d;
AY698449d; AY698450d;
AY698451d; AY698452d;
AY698484d; AY698485d;
AY698486d; AY698487d;
AY698488d; AY698489d;
AY698490d; AY698492d;
AY698493d
Shigella sonnei AY698418d; AY698419d;
AY698423d; AY698513d;
AY698514d; AY698515d
E < 1∗10−30 Penicillium canescens AY773333c; AY773334
Scopulariopsis sp AY773335
nos E < 1∗10−30 and 2× 20 bp Agrobacterium vitis plasmid pTiAB4 X77327
crye No
a“Native gene” means the native sequence from the microbial source of the transgene without codons modified. One codon-modified transgene, cp4
epsps, that has been introduced into GM crops has been analysed by FASTA, of which the results are summarised in Table 3. Coding sequences were
submitted to a FASTA search using default settings against the EMBL nucleotide databases for prokaryotes, bacteriophages, and fungi. The similarity
thresholds applied were E < 1∗10−30 and/or 2× 20 bp. Results for genes from the same microbial species as the gene source are not listed.
Abbreviations: ACC deaminase, 1-aminocyclopropane-1-carboxylate deaminase; bar, phosphinothricin acetyltransferase; bxn, bromoxynil nitrilase;
cp4 epsps, CP4 3-enolpyruvylshikimate-5-phosphate synthase; cry, crystalline insecticidal protein; dam, DNA adenine methylase; gox, glyphosate
oxidoreductase; nos, nopaline synthase; pat, phosphinothricin acetyltransferase; SAMase, S-adenosylmethionine hydrolase; uidA, β-glucuronidase.
bNucleotide accessions can be retrieved from the NCBI website [45].
cPutative function assigned to gene.
dPartial coding sequence.
eDetails on the individual cry genes tested and their accessions are provided in Table 4. In some of the genes, the coding sequences had been truncated
in analogy to the truncation of transgenes used for genetic modification of crops. For cry1Ab, the first 1944 nucleotides were used, corresponding to a
protein sequence of 648 amino acids. The truncated sequence of cry1Fa comprised the first 1815 nucleotides (605 amino acids). Full-length coding
sequences were used for cry1Ac (3537 bp), cry2Aa (1902 bp), cry2Ab (1902 bp), cry3Aa (1935 bp), cry3Bb (1959 bp), cry34Ab (372 bp), and cry35Ab
(1152 bp).
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Table 3. Similarities of the codon-modified cp4 epsps transgene introduced into herbicide-resistant GM soybean to microbial genes.
Transgenea Similarity Microorganism Gene accessionb
cp4 epsps E < 1∗10−30 and 2× 20 bp Brucella melitensis AE009625; AF326475
Brucella suis AE014291c
Mesorhizobium loti BA000012
Sinorhizobium meliloti AL591783c
E < 1∗10−30 Bartonella henselae BX897699c
Bartonella quintana BX897700c
Bradyrhizobium japonicum BA000040c
Caulobacter crescentus AE006017c
Rhodopseudomonas palustris BX572593c
a,b,c See legend to Table 2.
Conclusion
BXN activity is highly substrate-specific and the pu-
tative function relates to plant compound degradation.
Even though the bxn gene is derived from a potential hu-
man pathogen, no direct impact of this gene on human
or animal health is foreseen if it were to be transferred to
pathogens given the apparently specific role of this gene
in soil environments.
3-enolpyruvylshikimate-5-phosphate synthase
(cp4 EPSPS)
Microbial source
The source of the cp4 epsps gene was the soil bacterium
Agrobacterium strain CP4, which was one out of a group
of glyphosate-degrading bacteria (reviewed in [48]). Bac-
terial species of the genus Agrobacterium are all charac-
terised by the ability to form neoplastic lesions in plants
(eg, [49]).
Natural function
The 3-enolpyruvylshikimate-5-phosphate synthase
(EPSPS) enzyme catalyses an intermediate step in the
shikimate pathway for the synthesis of essential aromatic
precursor compounds of, among others, aromatic amino
acids and lignin, which is part of lignocellulose plant fi-
bres. EPSPS enzymes, also called AroA enzymes, occur in
a wide variety of organisms (eg, bacteria, fungi, plants).
EPSPS enzymes in plants are targets for the herbicide ac-
tive ingredient glyphosate, which binds and inhibits the
plant EPSPS enzymes. The EPSPS enzyme from Agrobac-
terium CP4, however, is not sensitive towards the action
of glyphosate (reviewed in [48]).
Function in GM crops
A number of commercialised GM crops contain the
cp4 epsps gene coding for the enolpyruvylshikimate-
phosphate synthetase (EPSPS) enzyme from Agrobac-
terium strain CP4, which confers resistance towards the
otherwise lethal herbicide glyphosate [48].
Natural prevalence
The amino acid sequences of EPSPS enzymes from
various species present in food (soybean, maize, E coli,
B subtilis, Saccharomyces cerevisiae) are divergent and the
identities that they share with the sequence of Agrobac-
terium CP4 EPSPS range from 24.1 to 41.1 percent [48].
Because of its relative insensitivity towards the inhibiting
action of glyphosate, the Agrobacterium CP4 EPSPS en-
zyme has been engineered into a number of crops to make
them glyphosate-resistant [48].
Geographical distribution
The geographical distribution of the cp4 epsps gene
and its source, Agrobacterium CP4, has not been specifi-
cally reported in literature. More generally, Agrobacterium
species occur globally in soils, for example, in the rhizo-
sphere of plants (eg, [50]).
Similarity to othermicrobial genes
The coding sequence of the native cp4 epsps gene
(Agrobacterium CP4, accession I43998 [45], size 1368 bp)
was used for FASTA analysis. The search results in
Table 2 show that a number of bacterial aroa genes
show a high degree of similarity to the epsps transgene.
These aroa genes are from Bradyrhizobium japonicum,
Caulobacter crescens, Gluconobacter oxydans, Mesorhi-
zobium loti, Rhodopseudomonas palustris, Silicibacter
pomeroyi, Sinorhizobium meliloti, and Zymomonas mo-
bilis, as well as of the pathogenic bacteria Bartonella quin-
tana, Bartonella henselae, Brucella melitensis, B melitensis
biovar abortus, and Brucella suis. The observed identities
probably relate to phylogenetic relationship, such as ob-
served between the genome of B suis and sequences of A
tumefaciens, B melitensis, M loti, and S meliloti [51, 52],
as well as between B henselae, B melitensis, and B quin-
tana [53]. The aroa genes of Brucella melitensis, B meliten-
sis biovar abortus, Brucella suis, Mesorhizobium loti, and
Sinorhizobium meliloti shared identical DNA stretches of
at least twice 20 bp with the transgenic sequence, which
is considered the minimum required for homologous re-
combination (Table 2).
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Table 4. cry transgenes present in GM crops that have been approved for food use.
Gene Target pest, class
Gene source,
Genbank accessiona ReferenceB thuringiensis
subspecies
cry1ab Lepidopterans Kurstaki M15271 [159]
cry1ac Lepidopterans Kurstaki M11068 [160]
cry1fa Lepidopterans Aizawai M63897 [161]
cry2aa Lepidopterans Kurstaki M31738 [162]
cry2ab Lepidopterans Kurstaki X55416 [163]
cry3aa Coleopterans Tenebrionis M30503 [164]
cry3bb Coleopterans EG4961 M89794 [165]
cry34ab and cry35ab Coleopterans PS149B1 AY011120 [166]
aNucleotide accessions can be retrieved from [45].
The sequence of the epsps transgene in GM soybean
has been described in literature [54]. The coding sequence
of this transgene was used for FASTA analysis (accession
AY125353 [45], size 1368 bp). The results were largely
similar to those with the native gene (see above), ex-
cept for the fact that the aroa genes from G oxydans, S
pomeroyi, and Z mobilis did not score suﬃciently with re-
spect to the threshold values (E < 1∗10−30; 2×20 bp; Table
3).
Known horizontal gene transfer activity
With regard to the location of the native gene within
the genome, the cp4 epsps gene has been isolated from
chromosomal DNA of Agrobacterium CP4 [55]. No in-
formation was found on the natural horizontal transfer
of aroa or epsps genes. Netherwood et al reported the
detection of the cp4 epsps gene in bacteria isolated from
small intestines of ileostomic patients who had consumed
transgenic soy, but not in bacteria from feces of healthy
subjects. These authors were, however, unable to cultivate
the bacteria with the transferred transgenes, preempting a
further confirmation of their results [20].
Selective conditions and environments
No specific information was available on the selective
advantage of the cp4 epsps transgene to microorganisms.
As previously mentioned, this gene was isolated from a
soil bacterium that was able to degrade glyphosate. It is
therefore conceivable in our view that the transfer of the
cp4 epsps sequence would convey a selective advantage
to microorganisms in glyphosate-treated soil, that is, the
ability to sustain glyphosate toxicity and to utilise it as a
substrate.
Potential for pathogenicity or virulence
The aroa gene, which codes for EPSPS, is consid-
ered a factor that influences the virulence of a number of
pathogenic microorganisms. Pathogenic bacteria with ei-
ther defective or without aroa genes (ie, aroa− mutants)
are unable to produce aromatic intermediates and there-
fore are auxotrophic, that is, dependent upon the supply
of aromatic substrates, such para-aminobenzoic acid. Be-
cause humans and animals do not produce aromatic pre-
cursors, the aroa− mutants of pathogens are unable to
multiply in their bodies.
Aroa− mutants of a number of pathogenic microor-
ganisms have been developed as candidates for live “at-
tenuated,” avirulent vaccines. For example, aroa−mutants
of Salmonella typhimurium and other Salmonella species
are well described in literature, also in combination with
other mutations (such as for adenine nucleotides) that
impact on virulence. While these mutants have been suc-
cessfully tested as oral vaccines against S typhimurium, for
example, in laboratory and domestic animals, they may
also serve as vehicle for transgenic protein antigens in re-
combinant vaccines, or for transgenic DNA in DNA vac-
cines. These vaccines exploit the mutants’ retained capac-
ity of S typhimurium to enter the host’s immune system
from the intestines, and thereby prime this system against
the antigens of interest (see, for review, [56, 57]).
In addition, the aroa genes of Pasteurella haemolyt-
ica, Pasteurella multocida, Haemophilus somnus, and
Aeromonas salmonicida have been mutated in pre-
commercial attenuated live vaccines for cattle, poultry,
and fish, as reported in scientific literature [58] and sec-
ondary information sources [59, 60, 61].
Reversion of auxotrophy in mutants by restoration of
aroa by horizontal transfer of transgenes would, in theory,
confer a selective advantage to the recipient.
In the FASTA analysis with the cp4 epsps genes present
in Agrobacterium CP4 and GM soybean, aroa genes from
Brucella showed a high similarity, including identical nu-
cleotide stretches of at least 2× 20 bp. Because Brucella is
an intracellular pathogen like Salmonella, it may be suit-
able for development as attenuated live vaccine or vaccine
carrier. Defective aromatic amino acid biosynthesis has
been associated with attenuation of Brucella, such as in
an aroC mutant of B suis [62] and an auxotrophic strain
of Brucella abortus [63]. There are currently no reports,
however, of specific aroa− mutants of B suis or B meliten-
sis as candidate attenuated oral vaccines.
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Conclusion
There is a widespread occurrence of EPSPS in nature,
which relates to its role as a “household” enzyme in many
organisms. With regard to mutated aroa genes of aroa−
oral vaccines, repair by homologous recombination of
these genes with the cp4 epsps transgene appears unlikely
given the lack of suﬃcient similarity between them. In ad-
dition, glyphosate, towards which CP4 EPSPS is insensi-
tive, does not have a role in treatment of human or animal
disease. Therefore, we conclude that there is no indication
that the potential transfer of the cp4 epsps gene from GM
crops to microorganisms would alter the pathogenicity of
the latter.
Glyphosate oxidoreductase (GOX)
Microbial source
The source organism Achromobacter LBAA was one of
the bacteria isolated from activated industrial and domes-
tic sludge that were capable of degrading glyphosate [64].
Natural function
The enzyme glyphosate oxidoreductase (GOX) hy-
drolyzes the C-N bond of glyphosate yielding amino-
methylphosphonic acid (AMPA) and glyoxylic acid. The
sequence of GOX has been reported to be unique. Oxy-
gen serves as a cosubstrate in the enzymatic reaction and
a putative flavin binding site for the FAD cofactor has been
identified at the N-terminus of GOX (reviewed in [48]).
Function in GM crops
GOX obtained from Achromobacter LBAA has been
introduced into some GM-crops together with glypho-
sate-resistant EPSPS (see above) in order to make these
crops glyphosate-resistant [48].
Natural prevalence
It has been widely observed that the soil microflora
converts glyphosate to AMPA. A limited number of stud-
ies address the GOX activity, by which glyphosate is con-
verted to AMPA and glyoxylic acid through lysis of the
C-N bond, within specific bacteria, such as from indus-
trial activated sludge that has been exposed to glyphosate
and byproducts of its production (eg, [65, 66] and ref-
erences cited herein). However, Forlani et al [67] ob-
served that bacteria isolated from soil were not capable
of utilising glyphosate as sole C or N source and con-
cluded that formation of AMPA should therefore be due
to non-culturable bacteria. In addition, Dick and Quinn
[68] observed that, unlike the lysis of the C-N bond by
GOX, isolated glyphosate-degrading soil microorganisms
cleaved the C-P bond of glyphosate. While GOX-activity
has been predominantly been observed in environments
containing glyphosate, it has recently been demonstrated
in a thermophilicGeobacillus, which unlikely had been ex-
posed to glyphosate. The function of this GOX activity in
absence of glyphosate is unknown [69].
Geographical distribution
We are not aware of reports describing the geograph-
ical dispersion of the gox genes. However, the occurrence
of Achromobacter species in the environment has been re-
ported to be widespread, for example, in Europe, Mid-
dle East, and Central America [70, 71, 72]. In addition,
the formation of AMPA from glyphosate in glyphosate-
treated soils has been reported in various regions, includ-
ing, among others, Europe, North and South America
[73, 74, 75].
Similarity to othermicrobial genes
The sequence used for FASTA analysis was the cod-
ing sequence of the native gox gene from Achromobacter
LBAA (sequence number 3, US patent 5 776 760 [64], size
1296 bp). No similarities that complied with the threshold
criteria were found (Table 2). The sequence of the trans-
genic gox transgene introduced into GM crops was not
available, however, and no FASTA analysis could thus be
performed on this sequence.
Selective conditions and environments
No specific data about a possible selective advantage
of the transfer of the gox gene for recipients were retrieved
from literature. As stated above, the gox gene was obtained
from a glyphosate-degrading bacterium that had likely
been exposed to glyphosate. The transfer of the gox gene
might, in our view, enable recipient microorganisms in
theory to sustain the toxicity of glyphosate and to utilise
it as a substrate.
Known horizontal gene transfer activity
Chromosomal DNA of Achromobacter LBAA has
served as source for the gox transgene, indicating that the
latter has a chromosomal location [64]. No information
was found on the natural horizontal transfer of aroa or
epsps genes.
Potential for pathogenicity or virulence
The gene source belonged to the Achromobacter
species, which can, in rare cases, cause human disease,
such as bacteremia due to A xylosoxidans [76, 77]. No data
were available on the possible role of gox in pathogenicity
or virulence of Achromobacter.
Conclusion
There is still uncertainty about the precise function
of GOX in its natural environment in the absence of
glyphosate. As discussed above, there is a background of
widespread microbial GOX-like activity in soil. In addi-
tion, glyphosate, which is converted by GOX, has no role
in the treatment of human and animal disease. Therefore,
we consider it unlikely that the potential transfer of GOX
from transgenic plants would exert a significant eﬀect on
the pathogenicity of recipient microorganisms.
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Phosphinothricin acetyltransferase (PAT)
Microbial source
Streptomyces hygroscopicus (bar gene) and Strepto-
myces viridochromogenes (pat gene) are streptomycetes
that occur in soil and that produce the natural herbi-
cide bialaphos (phosphinothricin-alanine-alanine). After
its release from bialaphos, phosphinothricin inhibits the
enzyme glutamine synthase, which is important in ni-
trogen metabolism, in plants and microorganisms (eg,
[78]). Another phosphinothricin-containing peptide is
phosalacine, produced by the streptomycete Kitasatospo-
ria phosalacinea [79]. In a more general sense, strepto-
mycetes are soil microorganisms. The production of an-
tibiotics, for example, streptomycin, and extracellular en-
zymes by streptomycetes is exploited on an industrial
scale.
Natural function
Phosphinothricin N-acetyl transferase (PAT, encoded
by bar and pat) inactivates phosphinothricin by acety-
lating the NH2 group. Besides the target substrate phos-
phinothricin, PAT also acetylates, to a lesser extent,
demethyl-phosphinothricin (DMPT), methionine sulfox-
imine (MSO), hydroxylysine, and glutamate [80, 81, 82].
Function in GM crops
PAT has been engineered into a number of crops, con-
veying resistance against the herbicide glufosinate, a syn-
thetic analogue of phosphinothricin. It serves either as
a marker of genetic transformation or for the purpose
of weed management in crops (see [80] and references
herein).
Natural prevalence
The ability to detoxify phosphinothricin has been ob-
served to be a prerequisite for its biosynthesis, so that this
compound cannot become toxic to its producer S hygro-
scopicus [83]. Wehrmann et al [80] mention that vari-
ous acetyltransferases from Streptomyces griseus, Strepto-
myces coelicolor, and Alcaligenes faecalis are also capable
of acetylating phosphinothricin with, however, compara-
tively weak aﬃnity. In addition, Bedford et al [84] men-
tion that such activity was also present in Streptomyces
lividans.
Geographical distribution
To our knowledge, there are no reports describing the
geographical distribution of the bar and pat genes. The
sources of the bar and pat genes, S hygroscopicus and S
viridochromogenes, belong to the streptomycetes, which
are ubiquitously occurring soil microorganisms.
Similarity to othermicrobial genes
For the FASTA analysis, the coding sequences of the
native genes of bar (S hygroscopicus, accession X05822
[45], size 552 bp) and pat (S viridochromogenes, M22827
[45], 552 bp) were used. These genes only shared with
each other similarities that complied with the threshold
criteria (Table 2). No FASTA analysis could be done on the
codon-modified bar and pat transgene sequences present
in GM crops, because they were unavailable.
Known horizontal gene transfer activity
The native genes of bar and pat isolated from S hygro-
scopicus and S viridochromogenes, respectively, are chro-
mosomally located [85, 86]. No accounts are known of
the horizontal transfer of the bar and pat genes from GM
plants to microorganisms.
Selective conditions and environments
No information was available on the selective advan-
tage that the introduction of PAT by horizontal trans-
fer may have on recipient microorganisms. As mentioned
above, the enzyme glutamine synthase, which is inhibited
by phosphinothricin analogues like glufosinate, has an es-
sential role in microorganisms. It is therefore conceivable
in our view that microorganisms in environments con-
taining glufosinate or other phosphinothricin analogues,
such as in herbicide-treated soils, would benefit fromPAT-
induced resistance against these compounds.
Potential for pathogenicity or virulence
With regard to the potential role of PAT in human
pathogenicity and virulence of microorganisms, no infor-
mation could be found.
Conclusion
PAT shows substrate specificity for phosphinothricin
and similar compounds (see above). Whereas phos-
phinothricin is considered a natural antibiotic, it has no
known application in the treatment of human and ani-
mal disease. We therefore conclude that the transfer of the
PAT enzyme is unlikely to confer increased pathogenicity
to pathogens.
Barnase and Barstar
Microbial source
The genes encoding Barnase and Barstar have been
cloned from Bacillus amyloliquefaciens. The first iso-
lates of B amyloliquefaciens obtained from soil produced
high levels of extracellular α-amylase, which distinguished
these bacteria from Bacillus subtilis (Fukumoto, 1943,
cited by [87]). This characteristic is exploited for indus-
trial production of the α-amylase enzyme.
Natural function
Barnase is a ribonuclease, which cleaves RNA yield-
ing 3′ nucleotides through a 2′, 3′-cyclic intermediate. Its
structure displays a characteristic fold formed by an α-
helix and an antiparallel β-sheet. Barstar is the inhibitor
of Barnase and both proteins form a one-to-one complex.
The structures of both proteins and their complex have
been the subject of study in many peer-reviewed articles
[88, 89].
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It has been hypothesised that Barnase may either serve
the utilisation of extracellular ribonucleotides or as a toxin
for other microorganisms. By binding to Barnase, Barstar
prevents B amyloliquefaciens from damage before it se-
cretes Barnase [89].
Function in GM crops
The ribonuclease Barnase from B amyloliquefaciens
has been cloned into some crops under control of a
tapetum-specific promoter. The expression of this con-
struct switches on specifically during anther development
such that it impairs pollen formation and makes the crop
male sterile.Male sterility is a useful trait for hybrid breed-
ing and has also been obtained by non-GMbreeding prac-
tices. Similar to GM crops expressing Barnase, “restorer”
crop lines with tapetum-specific expression of Barstar
have been developed. Crop fertility can be restored by
crossing a male-sterile crop line transgenic for Barnase
with a restorer line transgenic for Barstar [90].
Natural prevalence
Bacterial-, streptomycete-, and fungal-homologues of
the Barnase ribonuclease from B amyloliquefaciens have
been identified, including Binase (Bacillus intermedius),
St (Saccharopolyspora erythrea), T1 (Aspergillus oryzae),
C2 (Aspergillus clavatus), Ms (Aspergillus saitoi), U1 and
U2 (Ustilago sphaerogena; [88]). Several of the homol-
ogous fungal ribonucleases, for example, α-sarcin, are
part of a group of the so-called “ribotoxins.” The func-
tion of these ribotoxins, as well as that of other Barnase-
homologues, is not known. These ribonucleases all share
the same three-dimensional “barnase-fold” structure as
previously mentioned, with three conserved amino acid
residues (Glu, Arg, His) that are involved in the catalytic
reaction [88, 91].
In addition, homologues of Barstar have been found
in the streptomycetes Streptomyces aureofaciens (Sai14)
and S erythrea (Sti), which inhibit the Sa- and St-
ribonucleases, respectively, produced by these organisms
[92, 93].
Geographical distribution
No specific data are available on the geographical dis-
tribution of the occurrence of barnase and barstar genes
and their microbial source, B amyloliquefaciens.
Similarity to othermicrobial genes
The coding sequences of the native genes of barnase
(B amyloliquefaciens, accession M14442 [45], size 450 bp)
and barstar (B amyloliquefaciens, accession X15545 [45],
size 273 bp) were used for FASTA analysis. Barnase
showed high similarity to ribonuclease genes from other
Bacillus species (Table 2). Barstar did not show similarities
below the threshold E value (E < 1∗10−30). The sequences
of the codon-modified versions of these transgenes that
are present in GM crops were not known, and therefore
could not be analysed.
Known horizontal gene transfer activity
No information is provided on the location of the
genes, that is, chromosomal or plasmid-bound, by the
original reports that describe the isolation and cloning of
the native barnase and barstar genes from B amyloliquefa-
ciens [94, 95]. Another report describes the PCR amplifi-
cation of the barnase sequence located on a chromosomal
fragment of B amyloliquefaciens [96].
It has been suggested that the occurrence of ribonucle-
ases with the characteristic barnase-fold in both prokary-
otes and eukaryotes is indicative of either common ances-
try or horizontal gene transfer [97]. The occurrence in a
restricted number of organisms would indicate that these
ribonucleases have recently evolved [91].
Selective conditions and environments
There were no observations reported of a possible se-
lective advantage of the horizontal acquisition of the bar-
nase and barstar genes. However, we estimate that if the
role of barnase were to function as a toxin to other mi-
croorganisms, the barstar gene could convey a selective
advantage to its recipients.
Potential for pathogenicity or virulence
Unlike Bacillus cereus, which can cause food poison-
ing, B amyloliquefaciens, the source of the barnase and
barstar transgenes, neither exerts toxicity on cultured cells
nor produces enterotoxins, as reported in peer-reviewed
literature and in a regulatory product evaluation [98, 99].
Extracellular ribonucleases other than Barnase are
known to exert toxicity after cellular uptake, such as
by binding to receptors on the surface of prokaryotic-
and human cells [100, 101]. Ribonuclease(ribotoxin)-
deficient mutants of Aspergillus fumigatus have been cre-
ated by gene disruption through homologous recombina-
tion. Both wildtype andmutant strains were administered
to mice through the inhalatory route. The animals were
observed formortality during the experiment and for fun-
gal growth in lungs by postmortem histopathology. It was
thus observed that ribotoxin-deficient fungi were no less
pathogenic than wildtype strains in invasive Aspergillus-
mediated pulmonary infections (aspergillosis) [102]. An-
other study reported similar results [103]. Fungal ribonu-
cleases therefore do not appear to have an important role
in the pathogenicity of their hosts.
Conclusion
As stated above, B amyloliquefaciens, the source of the
barnase and barstar genes, is not known to be a pathogen,
unlike some other Bacillus species. However, the actual
function of Barnase in its native host, including its po-
tential role in pathogenicity and virulence, remains un-
clear. Barnase-related fungal ribonucleases do not appear
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to have a role in the pathogenicity of moulds, notwith-
standing their toxicity to cells. Based on this circumstan-
tial evidence, we conclude provisionally that the potential
transfer of the barnase and barstar transgenes is unlikely
to influence the pathogenicity of recipient microorgan-
isms.
DNA adeninemethylase (DAM)
Microbial source
The dam gene has been isolated from Escherichia coli
[104]. This bacterium is a common commensal intesti-
nal microorganism, while pathogenic strains may occur.
Pathogenic E coli strains can cause both intestinal and
extraintestinal disease. For example, intestinal symptoms
are caused by enteropathogenic (EPEC), enterotoxigenic
(ETEC), enterohaemorrhegic (EHEC), or enteroinvasive
(EIEC) E coli. Extraintestinal symptoms are caused, for
example, by uropathogenic (UPEC) E coli. Meningitis is
another example of an extraintestinal aﬀection caused
by particular strains of E coli. Genes involved with vir-
ulence of pathogenic E coli, such as those encoding ad-
hesins, siderophores, and toxins, are linked with mobile
genetic elements. These elements are not present in non-
pathogenic strains and probably have been introduced by
horizontal gene transfer [105].
Natural function
The DNA adenine methylase (DAM) enzyme reg-
ulates gene expression by methylation of adenine-N6
within the DNA sequence GATC [106].
By methylation of the transcription initiation site
where RNA polymerase binds, the expression of genes can
either be stimulated or inhibited. In addition, methyla-
tion can also aﬀect the binding of regulatory proteins to
DNA [106]. More generally, DAM has also a role in DNA
replication initiation and mismatch repair [107]. DAM-
activity is associated with protection of bacteria against
DNA damage, probably due to increased DNA breakage
by intrinsic enzymes in the absence of dam, which pre-
disposes DNA to further damage [108]. In addition, dam
protects again membrane damage by bile acids in the in-
testinal environment, which probably relates to the role of
dam in remodelling peptidoglycan, which can be part of
the bacterial envelope [108, 109].
Function in GM crops
DAM has been introduced into GM crops in order to
render them male-sterile, such as in maize approved for
commercialisation in the USA [29] and in experimental
maize [110]. In the commercialised maize, dam is said to
be expressed only in the anthers [29].
Natural prevalence
DAM activity has been reported for other γ-proteo-
bacteria besides E coli and also, among others, in cyano-
bacteria, archaebacteria, and spirochetes [104, 111, 112].
In addition, adenine-N6-methylating enzymes are en-
coded by bacteriophages, such as phage T4, which infects
E coli [113].
Geographical distribution
No specific data were available on the geographical
distribution of the native dam transgene. E coli has been
isolated from a wide variety of geographical backgrounds,
for example, from human and animal samples from dif-
ferent continents (eg, [114]).
Similarity to othermicrobial genes
The FASTA analysis was performed with the coding
sequence of the native dam gene (E coli, accession J01600
[45], size 837 bp). The results showed that this sequence
was present in the nonpathogenic E coli strain K-12, as
well as in the enterohaemorrhagic strain O157:H7 and the
uropathogenic strain CFT073 (results not shown). DAM
genes occur in other bacteria with high sequence similar-
ity to the native E coli gene, indicating widespread occur-
rence of this essential gene (Table 2). The occurrence of
many pathogenic bacteria among these results likely is ac-
counted for by the fact that the genomes of a wide array of
other γ-proteobacteria besides E coli have been sequenced.
The sequence of the codon-optimised DNA of the
dam transgene introduced into GM crops was not avail-
able. Therefore, no FASTA analysis could be performed
on this sequence.
Known horizontal gene transfer activity
The dam transgene is located on the chromosome of E
coli [104]. The DNA sequences of the dam genes of E coli
and phage T4 have diﬀerent AT-contents and are therefore
not similar. Based on the fact that a number of amino acid
residues appeared to have been conserved in the derived
protein sequences of both genes, a common evolutionary
origin was postulated [115].
Horizontal transfer, for example, by phage transduc-
tion, might restore the DAM activity within cells of dam-
deficient recipients. This has been shown with phage dam
genes artificially cloned into dam− E coli, which repaired
the methylation of plasmids by this bacterium (described,
eg, by [116, 117]).
Selective conditions and environments
As previously mentioned, DAM has a role in the pro-
tection of bacteria against damage to DNA and mem-
branes in the intestinal environment [108]. The transfer
of dam to intestinal bacteria deficient in this gene might
therefore, in our opinion, confer a selective advantage,
such as increased survivability.
Potential for pathogenicity or virulence
In pathogens like S typhimurium, DAM has been
shown to have an essential role in their virulence. Tar-
get sequences of DAM include multiple genes that are
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involved with the virulence of bacterial species, such as
the gene encoding the toxin-coregulated pilus (tcp) in
uropathogenic E coli, and DAM is therefore named a
“masterswitch” of bacterial virulence (reviewed in [106]).
Avirulent DAM-deficient mutants of pathogenic bac-
teria have been described. While these avirulent mutants
are able to induce an immune response, they are not as
invasive as the wildtype pathogens and occur in much
lower numbers in host tissues after oral administration,
yet are able to prime an immune response against subse-
quent challenges with the wildtype pathogen. Reversion to
virulence of dam− mutants by their transformation with
functional dam genes has been observed in animal exper-
iments [106].
The use of this technology for creating avirulent
pathogens as live vaccines may be commercialised in the
near future since the website of a biotechnology company
oﬀers DAM-deficient mutants for development of vac-
cines and vaccine carriers [118].
Conclusion
The dam transgene is derived from E coli, which
is a common resident of human intestines (eg, 8.0–
8.7 log cfu/g in fecal samples from positive infants [119]).
In addition, native dam occurs in both pathogenic and
nonpathogenic strains of E coli, while counterparts with
highly similar sequences occur widely in closely related
γ-proteobacteria, as described above. To our knowledge,
dam− live attenuated oral vaccines have not been com-
mercialised yet. Therefore, we assume that, given the con-
tinuous background presence of natural counterparts, the
potential transfer of the dam transgene would not impact
on the pathogenicity of recipient microorganisms.
1-aminocyclopropane-1-carboxylate (ACC)
deaminase
Microbial source
The gene encoding the 1-aminocyclopropane-1-
carboxylate (ACC) deaminase has been isolated from
Pseudomonas 6G5. Out of 600 bacteria isolated from soil,
this and another Pseudomonas bacterium showed abil-
ity to grow on minimal media containing ACC [120].
Members of the genus Pseudomonas belong to the γ-
proteobacteria, and are ubiquitous and diverse, compris-
ing strains that can be nonpathogenic or pathogenic to
plants, animals, and humans. The pathogenic traits have
been linked to the presence of genes that are absent from
nonpathogenic Pseudomonas [121].
Natural function
The enzyme ACC deaminase from Pseudomonas 6G5
diverts ACC into ammonia and ketobutyric acid [120].
The plant hormone ethylene is formed from ACC in
plants. Soil bacteria associated with roots of crops and
plants have been found to express ACC deaminase ac-
tivity. This activity suppresses the ethylene synthesis by
plants and causes increased root formation by these crops
(eg, [122]).
Function in GM crops
Introduction of the enzyme ACC deaminase into GM
tomatoes prevents ethylene formation in fruits, which in
turn delays fruit ripening [120].
Natural prevalence
The occurrence of ACC deaminase activity has been
described in plant growth promoting soil bacteria, in-
cluding strains of Alcaligenes, Bacillus, Enterobacter, Pseu-
domonas, Rhodococcus, Rhizobium, andVariovorax, as well
as from the yeastHansenula saturnus and the mould Peni-
cillium citrinum [122, 123, 124, 125]. Comparison of the
amino acid sequences of ACC deaminase enzymes from
bacteria, yeast, and mould shows a high degree of similar-
ity and the conservation of residues that are essential for
activity [126].
Geographical distribution
As stated above, the occurrence of bacteria of the
genus Pseudomonas is ubiquitous [121]. ACC deaminase-
containing microbes can be found in soil samples from
a wide range of origins, such as, for example, USA, Rus-
sia, a number of European countries, and Bhutan in Asia
[122, 124, 127]. No data were available on the distribution
of the ACC deaminase gene.
Similarity to othermicrobial genes
The coding sequence of the native ACC deaminase
gene from Pseudomonas 6G5 was used for FASTA analy-
sis (accession M80882 [45], size 1017 bp). This sequence
showed high similarity with the corresponding genes
from many soil bacteria species, as well as from the
yeast Schizosaccharomyces pombe and the fungus Penicil-
lium citrinum (Table 2). These similarities are in general
agreement with the similarities reported in literature (see
above). It was not possible to carry out the same analy-
sis on the sequence of the codon-modified version of the
ACC deaminase transgene that had been introduced into
GM crops, due to unavailability of this sequence.
Known horizontal gene transfer activity
The ACC deaminase gene was isolated from chromo-
somal DNA of Pseudomonas 6G5, indicating that it has a
chromosomal position [120]. There were no accounts of
the horizontal transfer of the ACC deaminase gene avail-
able in literature.
Selective conditions and environments
As previously mentioned, ACC deaminase allows its
microbial hosts to utilise ACC as a sole N-source, which,
in our view, would convey a selective advantage to mi-
croorganisms grown in the vicinity of plants, which pro-
duce ACC as an ethylene precursor.
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Conclusion
ACC deaminase is directed towards a plant hormone,
which is not present in humans and animals. In addition,
its gene from the gene source Pseudomonas 6G5 has simi-
lar counterparts in many related soil bacteria from a wide
range of geographic origins, as well as in some eukaryotic
microorganisms. We therefore conclude that the potential
transfer of the ACC deaminase transgene from GM crops
is unlikely to contribute to pathogenicity of recipient mi-
croorganisms.
S-adenosylmethionine hydrolase (SAMase)
Microbial source
The SAMase gene encoding the enzyme S-adeno-
sylmethionine hydrolase (SAMase), as used for genetic
modification, is derived from the E coli bacteriophage T3
[128].
Natural function
Hydrolysis of SAM by T3 SAMase yields 5′-methyl-
thioadenosine and homoserine [128].
The supposed function of native T3 SAMase is to in-
activate the host’s type I restriction endonuclease and to
deplete its cofactor S-adenosylmethionine (SAM) in E coli
cells infected by T3 [129]. This would protect the phage
from being degraded by the host’s DNA restriction activ-
ity.
In addition, artificial cloning of SAM hydrolase into
bacteria like E coli has been shown to reduce, among oth-
ers, DNA methylation and biosynthesis of quorum sens-
ing signaling molecules [130, 131, 132].
Function in GM crops
ACC is a precursor to the plant hormone ethylene,
while the formation of ACC involves reactions with SAM.
Hydrolysis of SAM by the transgenic enzyme SAMase, of
which the gene is under the control of a ripening stage-
specific promoter, inhibits ethylene formation and delays
fruit ripening in GM tomatoes [128].
Natural prevalence
The E coli bacteriophage T7, which is closely related
and highly similar to T3, does not contain the SAMase
gene. In addition, the gene and amino acid sequences
of the 0.3 protein from T7 phage, which also show anti-
restriction activity, do not show much similarity to those
of T3 SAMase [129].
Geographical distribution
No specific data were available on the geographical
distribution of the SAMase gene and its source, bacterio-
phage T3.
Similarity to othermicrobial genes
The native sequence of SAMase from bacteriophage
T3 was used for FASTA analysis (accession X04791 [45],
size 459 bp). This sequence shared a high degree of sim-
ilarity with the 0.3 gene, which fulfils the same function
in the bacteriophage phiYeO3-12 (Table 2). This “yersin-
iophage” infects Yersinia enterolytica serovar O:3 and its
genome sequence shows a high overall similarity to that of
T3 [133]. Interestingly, deletion of 0.3 gene from phiYe03-
12 did not impair the phage’s eﬃciency in vitro [134].
No data were available on the sequence of the codon-
modified SAMase transgene introduced into GM crops.
Therefore, it was not possible to carry out a FASTA analy-
sis with this sequence.
Known horizontal gene transfer activity
As previously mentioned, the native SAMase gene is
located on a bacteriophage. The similarities and diﬀer-
ences of the DNA, including the SAMase gene, between
bacteriophages T3, T7 and phiYe03-12 has led to the hy-
pothesis that T3might have originated from a recombina-
tion event between T7 and a yersiniophage. In a model ex-
periment, recombination between T7 and phiYe03-12 was
indeed observed in E coli that had been genetically mod-
ified with the O3 receptor of Y enterolytica in order to fa-
cilitate coinfection with both phages. The recombination
of the SAMase-like gene 0.3 of phiYe03-12 was not ob-
served in this case. The 0.3 gene was flanked upstream and
downstream by stretches of identical nucleotides, which
could be used for recombination, that is, horizontal trans-
fer [135].
Selective conditions and environments
Mutant phages with T3 SAMase deleted are not less
eﬃcient, and SAMase therefore appears not to be essential
for lytic activity (eg, [134]). We infer from this data that
transfer of SAMasewould not convey a selective advantage
to recipient phages.
Potential for pathogenicity or virulence
As mentioned above, the cloning of SAMase into bac-
teria suppresses, among others, DNA methylation and
biosynthesis of quorum sensing signaling molecules, both
of which are known to stimulate virulence of microorgan-
isms.
Conclusion
As mentioned above, the function of native SAMase is
to prevent bacteriophages from degradation by infected
bacterial hosts. In addition, expression of SAMase that
has been cloned into bacteria may indirectly suppress
pathogenicity of microorganisms by decreasing DNA
methylation and the biosynthesis of quorum sensing sig-
naling compounds. We conclude therefore that introduc-
tion of SAMase into mico-organisms by horizontal trans-
fer is unlikely to contribute to pathogenicity.
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β-glucuronidase (GUS)
Microbial source
The uidA gene, which codes for the β-glucuronidase
(GUS) enzyme, has been isolated from E coli (reviewed in
[136]). E coli is described in more detail in the section on
the dam gene.
Natural function
GUS hydrolyzes glucuronide-conjugated compounds
intracellularly in E coli, releasing the glucuronide [136].
The glucuronide released by GUS activity is used by E
coli as a carbon substrate for its metabolism [136].
Function in GM crops
The ability of GUS to convert chromogenic or fluoro-
genic substrates, yielding color or fluorescence develop-
ment by the reaction, has also been exploited in biotech-
nology by using GUS from E coli as a marker gene (re-
viewed in [137]). In addition, the use of transgenic maize
plants expressing GUS for commercial production of this
enzyme in purified form has also been reported [138].
Natural prevalence
E coli and other coliforms exhibit GUS activity. Be-
sides coliform bacteria, a limited number of other mi-
croorganisms, including Shigella, also display such activ-
ity. Bacteroides and Clostridium are among the gut res-
idents showing β-glucuronidase. Whereas their activity
was weaker than for E coli, these bacteria are generally
more numerous in the gut [136]. GUS activity of E coli
has been exploited for rapid tests to detect coliform bac-
teria in environmental, food, water, and clinical samples
[139], indicating ubiquitous presence of GUS-activity.
The allele frequency within a 587 bp fragment of
the uida gene has been studied in environmental GUS-
positive isolates of E coli. In this study, 114 alleles were
identified in 941 isolates, of which 60 alleles occurred in
two or more isolates [140].
Geographical distribution
As mentioned above, GUS and E coli are ubiquitously
present in a range of environments.
Similarity to othermicrobial genes
For the FASTA analysis, the coding sequence of the
native uidA gene coding for GUS from E coli (accession
S69414 [45], size 1812 bp) was used. Besides E coli, the 100
most similar sequences (E ≤ 4.7e-153) in the results of the
FASTA analysis within the prokaryote nucleotide database
were from Shigella species. Within the database for fungal
nucleotides, highly similar genes coding for GUS occurred
in Penicillium canescens and Scopulariopsis (Table 2).
No data were available on the sequence of the codon-
modified version of the uidA transgene present in GM
crops. Due to this lack of data, no FASTA analysis could
be carried out on the codon-modified uidA transgene.
Known horizontal gene transfer activity
The uida gene is located on the chromosome of E coli,
and is part of the GUS-operon [136]. The presence of
highly similar sequences coding for GUS in soil isolates
of P canescens and Scopulariopsis fungi and Arthrobacter
bacteria has recently been described. In this study, the hy-
pothesis was tested that gus genes would be amenable to
horizontal gene transfer from bacteria to fungi. This hy-
pothesis was based on the assumption that guswould con-
vey to fungi in soil the capacity to utilise glucuronides ex-
creted by animals as a source of carbon. Based on charac-
teristics of the gus genes and their products in these fungi
and Arthrobacter, the authors concluded that these genes
must have been derived from a common ancestor [141].
Selective conditions and environments
As mentioned previously, the horizontally transferred
uida gene is assumed by other authors to convey a se-
lective advantage to recipient soil microorganisms, since
GUS enables the utilisation of glucuronides derived from
animal excretions shed onto land [141].
Potential for pathogenicity or virulence
GUS activity is generally considered to be absent from
a minority of all E coli strains, including the pathogenic,
enterohaemorrhagic E coli O157:H7. The gus gene is still
present in this and other E coli strains lacking GUS ac-
tivity, the inactivity probably being caused by mutations
in this gene [142, 143, 144]. Recent reports, however, de-
scribe incidences of E coli O157:H7 showing GUS activity
(eg, [145]).
GUS activity contributes to the so-called enterohep-
atic circulation of hydrophobic compounds in humans
and animals. During this process, compounds are glu-
curonidated in the liver, excreted through the bile into the
gut, deglucuronidated by the gut flora, and subsequently
absorbed from the gut [136].
In addition, bacterial beta-glucuronidase activity has
been considered to be one of the factors that contribute to
the formation of gallstones in the liver. This is thought to
be due to the deglucuronidation of bilirubin glucuronides
present in the gall, which would facilitate the formation of
calcium bilirubinate, a component of gallstones [146].
Conclusion
As described above, there is a ubiquitous background
presence of GUS in a range of environments, includ-
ing the intestinal microflora. In addition, no link is evi-
dent between GUS and the pathogenicity of particular E
coli strains. We conclude therefore that it is unlikely that
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the horizontal transfer of GUS, if it would occur, would
have a noticeable impact on intestinal GUS activity or on
pathogenicity of recipient organisms.
Nopaline synthase (NOS)
Microbial source
The native tumor-inducing plasmid pTiC58 of
Agrobacterium tumefaciens strain C58 harbours among
others the gene nos encoding nopaline synthase. This plas-
mid is transferred to plants infected by A tumefaciens
causing the formation of calli, that is, “crown gall tumors”
[147].
Natural function
Nopaline synthase (NOS), which is also known as
nopaline dehydrogenase, catalyzes the formation of nopa-
line [N2-(1, 3-dicarboxypropyl)arginine] from the pre-
cursors α-ketoglutaric acid and arginine in an NADPH-
dependent reaction. It also catalyzes the formation of
ornaline [N2-(1, 3-dicarboxypropyl)ornithine] from α-
ketoglutaric acid and ornithine [147].
The transfer of the nos gene to infected plant cells trig-
gers the synthesis by these cells of nopaline, which is one
of the “opines” that can be utilised as substrate by A tume-
faciens [148]. For example, both “octopine” and “nopa-
line” types of crown galls can be discerned, while the latter
has been associated with nopaline synthase activity [147].
Function in GM crops
Nopaline synthase has been engineered into trans-
genic flax in order to serve as a transformation marker
that facilitated detection of transformed plant embryos
by the presence of nopaline (see the Canadian regulatory
evaluation document [149]).
Natural prevalence
The amino acid sequences of NOS and octopine syn-
thase share domains of comparatively high sequence sim-
ilarity with each other and, to a lesser degree, with dehy-
drogenase enzymes from other organisms [150]. Besides
Agrobacterium, related opine dehydrogenase enzymes also
occur in the bacterium Arthrobacter and aquatic inverte-
brates [151, 152]. In the latter, these enzymes have a role
in the anaerobic glycolysis, that is, in energy metabolism
[152].
Geographical distribution
No data were available on the geographical distribu-
tion of the nos gene. The microbial host of the pTiC58
plasmid, A tumefaciens C58, is able to grow in associa-
tion with plants around the globe [153]. More generally,
Agrobacterium species occur widely in soils from diﬀerent
geographical origins, as described above for the cp4 epsps
gene.
Similarity to othermicrobial genes
The coding sequence of the native nos gene from
Agrobacterium tumefaciens plasmid pTiC58 was used
for the FASTA analysis (accession AJ237588 [45], size
1242 bp). The results of this analysis showed that the nos
gene shared a high degree of similarity with the corre-
sponding gene on plasmid pTiAB4 of the related Agrobac-
terium vitis (Table 2). The actual sequence of the nos
transgene introduced into GM crops was not available
and therefore no analysis could be carried out on this se-
quence.
Known horizontal gene transfer activity
The microbial native nos transgene is located on plas-
mid pTiC58, as previously mentioned. In a model exper-
iment with nonsterile soil, the conjugative transfer of a
modified pTiC58 plasmid from Agrobacterium to other
bacteria was observed [154]. While this study did not
specifically analyze for the transfer of the nos gene, it
showed that the native plasmid carrying nos could be
transferred horizontally by conjugation.
The A vitis plasmid pTiAB4 shows similarity to other
plant “tumor-inducing” (Ti) plasmids, such as, for exam-
ple, a fragment containing the nos gene that was very sim-
ilar to the pTiC58 (source of the transgene). These simi-
larities were considered by Otten and De Ruﬀray [155] to
originate from horizontal transfer between Ti plasmids.
Selective conditions and environments
No data were available that in our opinion would in-
dicate a particular selective advantage for the nos gene to
recipients after its potential horizontal transfer.
Potential for pathogenicity or virulence
The nos gene has a role in the pathogenicity of its na-
tive hostA tumefaciens in plants, as described above, while
neither one is known to have a role in pathogenicity or
virulence of human or animal pathogens.
Conclusion
As mentioned above, the nos gene has a specific role
in plant pathogenesis by A tumefaciens. We therefore con-
clude that its potential horizontal transfer to microorgan-
isms would unlikely contribute to the latter’s human and
animal pathogenicity.
Cry proteins
Microbial source
The source of the cry genes used for genetic modifica-
tion of crops is Bacillus thuringiensis. This bacterium was
described for the first time in 1901 following its isolation
from diseased silkworm larvae. It was observed later that
these bacteria produced spores containing crystals that are
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toxic to insects. These crystals contain, among others, the
Cry proteins encoded by cry genes located on plasmids
and on the chromosome. The insecticidal properties of B
thuringiensis and its crystal inclusions have been exploited
for the production as biological pesticides since 1938 (re-
viewed in [156]).
The classification of subspecies of B thuringiensis is
based upon serological reactions of the H-flagellae [157].
The various cry genes that have been introduced in the
GM crops and their sources are mentioned in Table 4. In
addition, a website dedicated to the nomenclature of Cry
proteins provides the database accession and host strain
for each protein [158].
B thuringiensis, including the subspecies from which
the cry transgenes are derived, occurs ubiquitously in the
environment, including soil, water, sediment, plant leaves,
and food (eg, [167, 168, 169, 170]).
These Cry proteins are subdivided into various groups
based on the degree of similarity between their amino acid
sequences [171].
Natural function
The active subsequence of Cry proteins, which is re-
leased by enzymes in the insect gut, is composed of three
domains. Two of these domains participate in the bind-
ing of the Cry protein to aminopeptidase N receptor
molecules on the surface of epithelial cells lining the in-
sect gut. The third domain subsequently forms pores in
the cell membrane, leading to leaching and, finally, in-
sect lethality. Distinct classes of Cry proteins show ac-
tivities against specific insects, such as Cry1Ab against
Lepidoptera and Cry3Aa against Coleoptera (reviewed in
[172]).
The insecticidal mechanism is very specific as the Cry
proteins are not bound by intestinal tissues of humans and
experimental rodents, for which these proteins are non-
toxic (eg, [173]).
Function in GM crops
A number of insecticidal Cry proteins originating
from various strains of Bacillus thuringiensis have been
engineered into GM crops in order to protect these crops
from phytophagous (plant-feeding) insects (reviewed in
[174]).
Natural prevalence
Whereas the ubiquitous presence of B thuringiensis
strains has been acknowledged for a long time, studies
screening for the occurrence of cry genes are of a compar-
atively recent date. These studies were reviewed by Por-
car and Juarez-Perez [175]. The frequency of detection
may diﬀer from one particular type of cry gene to an-
other. For example, within the group of cry1 genes, which
are frequently observed, cry1F appears to be less common
than, for example, cry1A [175, 176]. In addition, combi-
nations of cry genes can be detected in single isolates of B
thuringiensis, which may be specific for certain strains, ge-
ographical origins, or ecological systems (eg, [177, 178]).
Cry sequences have also been identified in various
bacteria other than Bacillus thuringiensis. For example,
the cry16Aa and cry17Aa genes have been identified in a
strain of Clostridium bifermentans with insecticidal activ-
ity against dipterans [179].
In addition, cry genes have been identified in Paeni-
bacillus, including cry43Aa, cry43Ba, and cry43-like from
P lentimorbus [180], as well as cry18Aa from P popil-
liae [181]. Given that P popilliae acts diﬀerently from B
thuringiensis, that is, as a parasite of beetles (coleopterans)
rather than an insecticide, Zhang et al [181] argued that
the Cry18Aa protein should have a diﬀerent role in insect
pathology than that of the Cry proteins from B thuringien-
sis.
The amino acid sequence of the cry35ab gene prod-
uct from B thuringiensis PS149B1 shows similarity to the
41.9-kilodalton protein from Bacillus sphaericus. Inter-
estingly, both proteins are only toxic to target insects in
combination with a coexpressed protein, that is, Cry34Ab
and Cry35Ab in corn rootworm and the 41.9- and 51.4-
kilodalton proteins in mosquitoes [182, 183].
Geographical distribution
Similar to the occurrence of cry genes described above,
studies on the geographical distribution of these genes
have been carried out recently. These studies were re-
viewed by Porcar and Juarez-Perez [175], while additional
data have been published since then [176, 184, 185, 186].
The results of these studies indicate that in general many
cry genes are present in isolates of B thuringiensis from a
wide range of geographical origins, including Latin Amer-
ica, Asia, and Europe.
Similarity to othermicrobial genes
FASTA analysis of the native versions of the cry genes
that have been introduced into GM crops showed no sim-
ilarities of E < 1∗10−30 or minimally 2 × 20 bp other
than with other accessions for sequences from Bacillus
thuringiensis (Table 2). In some cases, that is, for cry1Ab
and cry1Ac, the highest E-value of the 100 best scoring
alignments (maximum output) with the prokaryote nu-
cleotide sequence database was still below the threshold
of E < 1∗10−30. The codon-modified versions of the cry
transgenes introduced into GM crops have not been anal-
ysed by FASTA, because their sequences were not avail-
able.
Known horizontal gene transfer activity
With regard to the presence of cry genes in Clostrid-
ium (see above), Barloy et al [179] suggested that mobile
elements, such as transposons, might have contributed to
the dissemination of these genes.
The native microbial cry transgenes occur both on
plasmids and in the chromosome of Bacillus thuringiensis
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(eg, [187]). Transfer of these genes by exchange of trans-
missible plasmids through conjugation with other strains
of B thuringiensis and Bacillus species has been observed
under laboratory conditions [188, 189].
Based on his review of structural similarities of the
various Cry proteins, de Maagd et al [172] postulated
that “domain swapping” might have occurred between cry
genes through homologous recombination. Such an ex-
change of domains can be accomplished under laboratory
conditions and can change the activity spectrum of the re-
sultant mutant Cry protein [172].
Selective conditions and environments
Cry proteins may constitute an important virulence
factor of strains of B thuringiensis and B cereus that are op-
portunistic insect pathogens [190].We therefore speculate
that horizontally transferred cry genes would, in theory,
convey a selective advantage to recipient microorganisms
lacking these genes within the insect environment.
Potential for pathogenicity or virulence
B thuringiensis is genetically related to Bacillus an-
thracis and B cereus, which are known pathogens, B
anthracis causing anthrax and B cereus causing oppor-
tunistic infections. The specific phenotypic characteris-
tics of B thuringiensis and B anthracis are associated with
extrachromosomal elements [191]. Based upon exten-
sive review of the safety data on B thuringiensis to ani-
mals and humans, various sources have concluded that B
thuringiensis preparations are safe (eg, [157, 192]).
Conclusion
As described above, native cry genes display ubiqui-
tous presence and have also been detected in foods. Over-
all reviews of safety data indicate that there is no toxicity
of Cry proteins to humans [157, 174, 192]. We therefore
conclude that the horizontal gene transfer of cry genes
from plants to microorganisms, if it would occur, is un-
likely to contribute to pathogenicity of recipient microor-
ganisms in humans and domestic animals.
DISCUSSION
The microbial genes that have been introduced into
market-approved GM crops constitute a fairly heteroge-
nous group with regard to source and function in mi-
croorganisms. In the safety assessment of these crops so
far, the focus has been on antibiotic resistance genes. In
this work, the function and characteristics of microbial
transgenes other than antibiotic resistance genes as well
as the potential health aspects of their horizontal transfer
have been discussed. In the survey, we took into account
characteristics of the transgenes that might be relevant
to health. These characteristics included the microbial
source of the native transgene; the function of the trans-
gene in its natural environment and in genetically modi-
fied crops; the natural prevalence and geographical distri-
bution of the native and similar transgenes; the homology
to genes of othermicrobial species, which is also indicative
for the background presence and the likelihood of trans-
fer, that is, by homologous recombination; known hori-
zontal transfer activity of the transgene; and the poten-
tial contribution of the transgene to pathogenicity or vir-
ulence of human and animal microbial pathogens. Each
single item may not be totally predictive of gene transfer
and associated health eﬀects and therefore the “weighed
evidence” of the items in combination should be consid-
ered. In many cases, it was noted that there was a wide-
ranging background presence, a specific function, or an
apparent lack of relationship with pathogenicity of the
gene considered. We concluded for each gene that its po-
tential horizontal transfer to microorganisms would un-
likely raise health concerns.
In addition, we noted some conspicuous items for
the genes considered. For example, the presence in soil
fungi of analogues of the bacterial gene coding for β-
glucuronidase might originate from a horizontal transfer
between bacteria and fungi, as reported recently in litera-
ture [141]. Interestingly, this gene was considered by the
author of the study to convey a selective advantage to the
recipient fungi, since it would allow for utilisation of glu-
curonides from excretions (feces, urine) of animals. In a
more general sense, we may extend this to survival and
competitive advantage of microorganisms in the environ-
ment, including the soil. In this respect, also the trans-
fer of herbicide resistance genes may, in theory, provide
a selective advantage to soil microorganisms sensitive to
herbicide action, as may the transfer of the ACC deami-
nase gene to microorganisms colonising the rhizosphere
of plants. It may be speculated that an increased surviv-
ability of pathogens in the environment may indirectly in-
crease the likelihood of exposure to these pathogens.
Another conspicuous item was the presence in live at-
tenuated oral vaccines of mutated aroa genes, which are
functional analogs of the cp4 epsps transgene in herbicide-
resistant crops. We consider the likelihood of repair of
the mutant genes by homologous recombination with the
transgene to be comparatively low or absent, given the
lack of similarity to aroa genes in precommercial vaccines
and the background presence of aroa genes in other mi-
croorganisms. Some experimental GM crops have been
modified with bacterial aroa genes other than cp4 epsps,
such as aroa from S typhimurium, of which mutants have
also been used as attenuated live vaccines. A discussion on
experimental GM crops is, however, beyond the scope of
this paper.
Some of these experimental GM crops may enter
the market in the near future and contain novel traits
and transgenes, which should also be assessed for their
safety by a comparative safety assessment [3]. The sec-
tion on gene transfer of the FAO/WHO Codex Alimenta-
rius guidelines for the safety assessment of foods derived
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from GM crops focuses on antibiotic resistance [2]. The
potential impact of gene transfer on the pathogenicity of
recipient microorganisms is also an important item in
practice, however. We therefore recommend considering
the abovementioned items, including the characteristics
of transgenes and their native counterparts, in the safety
assessment of GMOs carrying transgenes other than those
reviewed in this paper.
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